Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial

NameINFECTIOUS DISEASES INSTITUTE
Activity TitleSwitch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial
DetailsJournal club
CompetenceGeneral Medicine
Start Date22-07-2024
End Date22-07-2024
Event Time09:00 AM
Locationzoom
Cost (UGX)0
CPD Points1